GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis
about
GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
GLP-1 receptor agonist added t ...... matic review and meta-analysis
@en
GLP-1 receptor agonist added t ...... matic review and meta-analysis
@nl
type
label
GLP-1 receptor agonist added t ...... matic review and meta-analysis
@en
GLP-1 receptor agonist added t ...... matic review and meta-analysis
@nl
prefLabel
GLP-1 receptor agonist added t ...... matic review and meta-analysis
@en
GLP-1 receptor agonist added t ...... matic review and meta-analysis
@nl
P50
P921
P356
P1476
GLP-1 receptor agonist added t ...... matic review and meta-analysis
@en
P2093
Francesco Brescia
Luigi Laviola
P356
10.1002/DMRR.3082
P577
2018-10-18T00:00:00Z